EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Profile of alglucosidase alfa in the treatment of Pompe disease: safety, efficacy, and patient acceptability

Ilka Schneider, Stephan Zierz

Research and Reports in Endocrine Disorders · 2016

DOI: 10.2147/rred.s72834 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research and Reports in Endocrine Disorders, 2016. Verfasst von Ilka Schneider und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Schneider, I., & Zierz, S. (2016). Profile of alglucosidase alfa in the treatment of Pompe disease: safety, efficacy, and patient acceptability. Research and Reports in Endocrine Disorders. https://doi.org/10.2147/rred.s72834

Vancouver

Schneider I, Zierz S. Profile of alglucosidase alfa in the treatment of Pompe disease: safety, efficacy, and patient acceptability. Research and Reports in Endocrine Disorders. 2016. doi:10.2147/rred.s72834

BibTeX
@article{Schneider2016,
  author = {Schneider, Ilka and Zierz, Stephan},
  title = {Profile of alglucosidase alfa in the treatment of Pompe disease: safety, efficacy, and patient acceptability},
  journal = {Research and Reports in Endocrine Disorders},
  year = {2016},
  doi = {10.2147/rred.s72834}
}
Kostenlos starten →